↓ Skip to main content

Modulation of NK cells with checkpoint inhibitors in the context of cancer immunotherapy

Overview of attention for article published in Cancer Immunology, Immunotherapy, April 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
2 X users
patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
74 Mendeley
Title
Modulation of NK cells with checkpoint inhibitors in the context of cancer immunotherapy
Published in
Cancer Immunology, Immunotherapy, April 2019
DOI 10.1007/s00262-019-02336-6
Pubmed ID
Authors

Beatriz Sanchez-Correa, Nelson Lopez-Sejas, Esther Duran, Fernando Labella, Corona Alonso, Rafael Solana, Raquel Tarazona

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 74 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 15%
Researcher 9 12%
Student > Ph. D. Student 9 12%
Student > Bachelor 6 8%
Student > Doctoral Student 4 5%
Other 14 19%
Unknown 21 28%
Readers by discipline Count As %
Immunology and Microbiology 13 18%
Biochemistry, Genetics and Molecular Biology 12 16%
Medicine and Dentistry 12 16%
Agricultural and Biological Sciences 7 9%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 7 9%
Unknown 21 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2022.
All research outputs
#7,480,508
of 26,017,215 outputs
Outputs from Cancer Immunology, Immunotherapy
#1,004
of 3,029 outputs
Outputs of similar age
#130,781
of 369,634 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#5
of 20 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 3,029 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,634 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.